Bacillus Calmette-Guérin (BCG) and Beyond: Is Systemic Immunotherapy for BCG-Naïve Non–Muscle-Invasive Bladder Cancer Progress or Overreach?

Ashish M. Kamat

Patrick J. Hensley

Department of Urology, University of Kentucky Markey Cancer Center, Lexington, KY

Brigida A. Maiorano

Department of Medical Oncology, IRCCS San Raffaele Hospital, Comprehensive Cancer Center, Milan, Italy

Roger Li

Department of Genitourinary Oncology Moffitt Cancer Center Tampa Florida USA

Sarah P. Psutka

University of Washington School of Medicine, Seattle, WA

Kent W. Mouw

Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

Amir Horowitz

1Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, United States

Shilpa Gupta

Department of Hematology and Medical Oncology Taussig Cancer Institute Cleveland Clinic Cleveland Ohio USA

Andrea Necchi

Department of Medical Oncology Fondazione IRCCS Istituto Nazionale dei Tumori University of Milan Milan Italy